AngelMan92 wrote: Please do yourself a favor and do your own DD and watch the Webcast in it's full form from the Sedar site document's link.
Stagezero is FIRST AND FOREMOST a cancer screening company
Aristotle has been in development for 15 years
COVID has impacted the healthcare system heavily (revenue has dipped heavily as a result of haulting the health systems)
Testing in Arizona, where the positive rate is extremely high
Stage considers itself as a company that can not only survive this pandemic but strive in light of it.
Stage has a turnaround of 2-3 days (often 2 days) on COVID tests so they are building many clients
No pop up Covid sites as they are not profitable and often enough illegal
Stage foresees their heavy demand to continue until the end of 2021 (24 months)
Aristotle is still set to launch at year's end
"Don't trust Stockhouse, they make things up" HAHAHAHH
Their current partners work with the ideology "come for COVID, stay for CANCER"
The company is ramping up and continuing to strive
Alot of their orders are paid, in the bank
The other cancer tests on the market, do not have specificity (they only tell you what cancer it is at a 50% chance as opposed to Arist. 99%)
Aristotle will take over Colonsentry as it is even able to tell you whether you are Stage 1,2,3, or 4.
When you have a product that is better for the health and the cost structure, then we have EVERYONE's attention
We have done 1 million$ in revenue in 6 weeks of Q3
No Projections are possible right now as things are just too volatile, so we will be updated as things go on
Let me know if I missed anything,
Brad